Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Adelstein

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Anticancer Research|January 9, 2021
Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit MetastasisTimothy D Smile, David X Xiong, Vamsi Varra, et al.
The Journal of Clinical Investigation|March 2, 2021
Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinomaCan F Koyuncu, Cheng Lu, Kaustav Bera, et al.
Cancer|March 14, 2020
Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysisJames R Broughman, David D Xiong, Benjamin J Moeller, et al.
Head & Neck|September 12, 2020
Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration studySara W Liu, Neil M Woody, Wei Wei, et al.
Oral Oncology|October 31, 2020
Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial designChristopher W Fleming, Matthew C Ward, Neil M Woody, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2025
Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxxChristina L Runge, Jessica A Lyness, Maura L Gillison, et al.
Head & Neck|September 28, 2012
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, VirginiaDavid J Adelstein, John A Ridge, David M Brizel, et al.
Cancer|September 6, 2022
Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinomaCan F Koyuncu, Reetoja Nag, Cheng Lu, et al.
Lancet (London, England)|November 20, 2018
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trialMaura L Gillison, Andy M Trotti, Jonathan Harris, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Anticancer Research|January 9, 2021
Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit MetastasisTimothy D Smile, David X Xiong, Vamsi Varra, et al.
The Journal of Clinical Investigation|March 2, 2021
Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinomaCan F Koyuncu, Cheng Lu, Kaustav Bera, et al.
Cancer|March 14, 2020
Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysisJames R Broughman, David D Xiong, Benjamin J Moeller, et al.
Head & Neck|September 12, 2020
Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration studySara W Liu, Neil M Woody, Wei Wei, et al.
Oral Oncology|October 31, 2020
Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial designChristopher W Fleming, Matthew C Ward, Neil M Woody, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2025
Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxxChristina L Runge, Jessica A Lyness, Maura L Gillison, et al.
Head & Neck|September 28, 2012
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, VirginiaDavid J Adelstein, John A Ridge, David M Brizel, et al.
Cancer|September 6, 2022
Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinomaCan F Koyuncu, Reetoja Nag, Cheng Lu, et al.
Lancet (London, England)|November 20, 2018
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trialMaura L Gillison, Andy M Trotti, Jonathan Harris, et al.
Pageof 11